CD274 and hepatocellular carcinoma: In the administration of atezolizumab, an anti-PD-L1 antibody, one patient with metastatic bladder cancer developed a corneal ulcer in both eyes [15], while another patient with unresectable hepatocellular carcinoma developed corneal perforation in the left eye only [16].